2nd Quarter - Report

HEALTHFUTURES, LLC for LIFE TECHNOLOGIES

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Personalized medicine Health Care Reform, Comparative effectiveness research

LobbyistCovered position, as disclosed
JENNIFER RACHEL LEIB —
ROBERT WELLS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Food Industry (safety, labeling, etc.) FOO

Pathogen detection S. 510, FDA Food Safety Modernization Act HR 759, Food and Drug Administration Globalization Act.

LobbyistCovered position, as disclosed
JENNIFER RACHEL LEIB —
ROBERT WELLS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 759 (111th), S. 510 (111th)

Medical/Disease Research/Clinical Labs MED

No bill#, Genomics and Personalized Medicine Act

LobbyistCovered position, as disclosed
JENNIFER RACHEL LEIB —
ROBERT WELLS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.